| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | CN1350592A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/22/2002 | CN1350542A Xylo-LNA analogues |
| 05/22/2002 | CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350527A Aminomethylpyrrolidine derivatives having aromatic substituents |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/22/2002 | CN1350445A Treatment of hepatitis C using hyperthermia |
| 05/22/2002 | CN1350435A A composition containing carvacrol and thymol for use as abactericide |
| 05/22/2002 | CN1350428A Microbially resistant compositions |
| 05/22/2002 | CN1349823A Making process of enzyme degrading oral liquid |
| 05/22/2002 | CN1349819A Myocarditis treating Chinese medicine prepn |
| 05/22/2002 | CN1349811A Composite Chinese medicine for treating viral myocarditis |
| 05/22/2002 | CN1349806A Hypoglycemic and antiphthitic medicine for treating diabetes and phthisis |
| 05/22/2002 | CN1349799A Chinese medicine Hanhui prepn |
| 05/22/2002 | CN1085213C Triazole derivatives useful in therapy |
| 05/22/2002 | CN1085212C Rapamycin 42-oximes and hydroxylamines |
| 05/22/2002 | CN1085211C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/22/2002 | CN1085205C Bicyclic amino acids |
| 05/22/2002 | CN1085087C External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof |
| 05/22/2002 | CN1085086C Capsule for treatment of AIDS and preparing mehtod thereof |
| 05/22/2002 | CN1085084C Medicine for treating acute-chronic abdominal troubles and its preparing method |
| 05/21/2002 | US6392100 Antiinflammatory agents; antiproliferative agents; immunosuppressants; viricides |
| 05/21/2002 | US6392085 Therapeutic nucleosides |
| 05/21/2002 | US6392082 Triazole derivatives having antifungal activity |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
| 05/21/2002 | US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391903 Triazole derivatives having antifungal activity |
| 05/21/2002 | US6391879 Therapeutic anti-fungal nail preparation |
| 05/21/2002 | US6391631 Nucleotide sequences for use as tools in genetic engineering and analysis |
| 05/21/2002 | US6391567 Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| 05/21/2002 | US6391325 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials |
| 05/21/2002 | US6391315 Composition comprising mixed antigens derived from both cell surface extracts and cultured broth, treated by chromatography to obtain effective fraction free of endotoxin and whole cells |
| 05/21/2002 | US6391313 Vaccine comprising at least three antigens from hemophilus influenzae and at least one antigen from moraxella catarrhalis to protect against disease caused by both bacteria, including otitis media |
| 05/21/2002 | US6391304 Medicinal product capable of inducing protection in feline host against infection with feline immunodeficiency virus, comprising isolated peptide consisting of or containing specified amino acid sequence |
| 05/21/2002 | US6391285 Antimicrobial polypeptide and methods of use |
| 05/21/2002 | US6390821 Phosphorylation |
| 05/21/2002 | CA2230750C Antiherpes peptidomimetic compounds |
| 05/21/2002 | CA2082636C Process for the preparation of sulfonylpristinamycin iib |
| 05/21/2002 | CA1341359C Manufacturing process for a single-cell lifeform killing or growth inhibiting composition containing fluorine (f-) and lithium (li+) |
| 05/16/2002 | WO2002039116A2 Retrovirus isolated from humans |
| 05/16/2002 | WO2002038770A1 Yeast derived vaccine against ipnv |
| 05/16/2002 | WO2002038769A2 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 |
| 05/16/2002 | WO2002038610A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038577A2 Extended release erythromycin derivatives |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038564A1 NOVEL β-LACTAM COMPOUNDS AND PROECSS FOR PRODUCING THE SAME |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038554A1 Amide derivatives |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038528A1 Pleuromutilin derivatives with antimicrobial activity |
| 05/16/2002 | WO2002038266A1 Apparatus and method for producing antimicrobial silver solution |
| 05/16/2002 | WO2002038181A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/16/2002 | WO2002038177A2 Adjuvant combination formulations |
| 05/16/2002 | WO2002038174A2 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038156A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria |
| 05/16/2002 | WO2002038153A1 New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002026943A3 Production of virus-like hcv particles in the cells of insects |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002026697A3 Aromatic derivatives with hiv integrase inhibitory properties |
| 05/16/2002 | WO2002020054A3 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy |
| 05/16/2002 | WO2002020026A3 Treatment of drug resistant organisms with nitric oxide |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002018448A3 Percarboxylated polysaccharides, and a process for their preparation |
| 05/16/2002 | WO2002008204A3 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2002003971A3 Pharmaceutical composition and method for the treatment of retroviral infections |
| 05/16/2002 | WO2002000593A3 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001097851A3 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 05/16/2002 | WO2001097792A3 Neuraminidase inhibitors in the treatment of equine influenza virus infection |
| 05/16/2002 | WO2001095890A3 Oral pharmaceutical compositions containing terbinafine |
| 05/16/2002 | WO2001087333A3 Immune system stimulating means |
| 05/16/2002 | WO2001087289A3 Propofol for treatment of sepsis |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081372A3 Vancomycin analogs |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001074341A3 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001066100A3 Pharmaceutical composition |
| 05/16/2002 | WO2001062668A3 Sulfur containing compounds |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001039802A9 Chimeric flavivirus vaccines |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058804 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-Michael catalytic activity; antitumor; anticarcinogenic agents |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |